IQVIA Holdings Inc.

The global clinical trials market is projected to grow from $127.16 billion in 2025 to $176.32 billion by 2030, with a CAGR of 6.8%. Growth is driven by AI-enabled trial design, decentralized and virtual trials, precision medicine, and real-world evidence studies. North America leads the market while Asia-Pacific is the fastest-growing region. St...

The global Pharmacovigilance Automation Market is expected to grow at a CAGR of 6.50% from 2025 to 2035, driven by increasing AI adoption, stringent drug safety regulations, and rising adverse event reporting volumes. North America leads with 38.60% market share, while Europe shows the fastest growth at 18.9% CAGR. Software solutions dominate wit...

The global decentralized clinical trials market is projected to grow from USD 9.9 billion in 2025 to USD 38.3 billion by 2035, at a CAGR of 14.5%. Growth is driven by digital health technologies, remote patient engagement, and ecosystem expansion involving CROs and platform vendors. Oncology represents the largest therapeutic segment at 45% marke...

Dark Horse Consulting Group and KunTuo Medical Research and Development have signed a Memorandum of Understanding to establish a strategic collaboration providing biotherapeutics developers with an integrated pathway for conducting clinical trials in China. The partnership combines DHCG's regulatory and consulting expertise with KunTuo's clinical...

Following a market rally driven by US-Iran peace deal hopes and strong tech earnings, eight underperforming US stocks are identified as having significant upside potential of 25-85%. While the S&P 500 and NASDAQ reached record highs, certain stocks have fallen 10-20% over two weeks despite strong fundamentals. IQVIA and Sonoco are highlighted as ...